BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34323419)

  • 41. c-mip impairs podocyte proximal signaling and induces heavy proteinuria.
    Zhang SY; Kamal M; Dahan K; Pawlak A; Ory V; Desvaux D; Audard V; Candelier M; BenMohamed F; Matignon M; Christov C; Decrouy X; Bernard V; Mangiapan G; Lang P; Guellaën G; Ronco P; Sahali D
    Sci Signal; 2010 May; 3(122):ra39. PubMed ID: 20484117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystinosin deficiency causes podocyte damage and loss associated with increased cell motility.
    Ivanova EA; Arcolino FO; Elmonem MA; Rastaldi MP; Giardino L; Cornelissen EM; van den Heuvel LP; Levtchenko EN
    Kidney Int; 2016 May; 89(5):1037-1048. PubMed ID: 27083281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.
    Beeken M; Lindenmeyer MT; Blattner SM; Radón V; Oh J; Meyer TN; Hildebrand D; Schlüter H; Reinicke AT; Knop JH; Vivekanandan-Giri A; Münster S; Sachs M; Wiech T; Pennathur S; Cohen CD; Kretzler M; Stahl RA; Meyer-Schwesinger C
    J Am Soc Nephrol; 2014 Nov; 25(11):2511-25. PubMed ID: 24722446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.
    White JT; Zhang B; Cerqueira DM; Tran U; Wessely O
    Development; 2010 Jun; 137(11):1863-73. PubMed ID: 20431116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
    Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
    J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
    Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish.
    O'Brien LL; Grimaldi M; Kostun Z; Wingert RA; Selleck R; Davidson AJ
    Dev Biol; 2011 Oct; 358(2):318-30. PubMed ID: 21871448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
    Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
    Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.
    Gellermann J; Stefanidis CJ; Mitsioni A; Querfeld U
    Pediatr Nephrol; 2010 Jul; 25(7):1285-9. PubMed ID: 20191369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
    Dong J; Jiang Z; Ma G
    Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin.
    Li Y; Xu Z; Deng H; Liu M; Lin X; Zhang M; Li G; Yue S; Gao X
    Biochem Biophys Res Commun; 2023 Jan; 639():176-182. PubMed ID: 36495766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sirolimus interacts with pathways essential for podocyte integrity.
    Letavernier E; Bruneval P; Vandermeersch S; Perez J; Mandet C; Belair MF; Haymann JP; Legendre C; Baud L
    Nephrol Dial Transplant; 2009 Feb; 24(2):630-8. PubMed ID: 18927120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
    Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
    Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
    Petrakis I; Mavroeidi V; Stylianou K; Andronikidi E; Lioudaki E; Perakis K; Stratigis S; Vardaki E; Zafeiri M; Giannakakis K; Plaitakis A; Amoiridis G; Saraiva MJ; Daphnis E
    Amyloid; 2013 Sep; 20(3):164-72. PubMed ID: 23829269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The decreases of nephrin and nuclear WT1 in podocytes may cause albuminuria during the experimental sepsis in mice.
    Kato T; Mizuno S; Kamimoto M
    Biomed Res; 2010 Dec; 31(6):363-9. PubMed ID: 21187647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
    Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
    Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
    Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
    Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the knockdown of Cabin1 on p53 in glomerular podocyte.
    Wen Y; Zhou P; Liu L; Wang Z; Zhang Y; Liang J
    J Recept Signal Transduct Res; 2016; 36(2):173-80. PubMed ID: 26400065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.
    Srichai MB; Konieczkowski M; Padiyar A; Konieczkowski DJ; Mukherjee A; Hayden PS; Kamat S; El-Meanawy MA; Khan S; Mundel P; Lee SB; Bruggeman LA; Schelling JR; Sedor JR
    J Biol Chem; 2004 Apr; 279(14):14398-408. PubMed ID: 14736876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.